• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于向MCF-7乳腺癌细胞进行基因递送的壳聚糖-微小RNA纳米复合物的物理化学和生物学特性

Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells.

作者信息

Santos-Carballal B, Aaldering L J, Ritzefeld M, Pereira S, Sewald N, Moerschbacher B M, Götte M, Goycoolea F M

机构信息

Institute of Plant Biology and Biotechnology (IBBP), University of Münster, Schlossgarten 3, D-48149 Münster, Germany.

Organic and Bioorganic Chemistry, Bielefeld University, Universitätsstrasse 25, D-33615 Bielefeld, Germany.

出版信息

Sci Rep. 2015 Sep 1;5:13567. doi: 10.1038/srep13567.

DOI:10.1038/srep13567
PMID:26324407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4555168/
Abstract

Cancer gene therapy requires the design of non-viral vectors that carry genetic material and selectively deliver it with minimal toxicity. Non-viral vectors based on cationic natural polymers can form electrostatic complexes with negatively-charged polynucleotides such as microRNAs (miRNAs). Here we investigated the physicochemical/biophysical properties of chitosan-hsa-miRNA-145 (CS-miRNA) nanocomplexes and the biological responses of MCF-7 breast cancer cells cultured in vitro. Self-assembled CS-miRNA nanocomplexes were produced with a range of (+/-) charge ratios (from 0.6 to 8) using chitosans with various degrees of acetylation and molecular weight. The Z-average particle diameter of the complexes was <200 nm. The surface charge increased with increasing amount of chitosan. We observed that chitosan induces the base-stacking of miRNA in a concentration dependent manner. Surface plasmon resonance spectroscopy shows that complexes formed by low degree of acetylation chitosans are highly stable, regardless of the molecular weight. We found no evidence that these complexes were cytotoxic towards MCF-7 cells. Furthermore, CS-miRNA nanocomplexes with degree of acetylation 12% and 29% were biologically active, showing successful downregulation of target mRNA expression in MCF-7 cells. Our data, therefore, shows that CS-miRNA complexes offer a promising non-viral platform for breast cancer gene therapy.

摘要

癌症基因治疗需要设计出能携带遗传物质并以最小毒性进行选择性递送的非病毒载体。基于阳离子天然聚合物的非病毒载体可与带负电荷的多核苷酸(如微小RNA(miRNA))形成静电复合物。在此,我们研究了壳聚糖-hsa-miRNA-145(CS-miRNA)纳米复合物的物理化学/生物物理性质以及体外培养的MCF-7乳腺癌细胞的生物学反应。使用具有不同乙酰化程度和分子量的壳聚糖,以一系列(+/-)电荷比(从0.6到8)制备了自组装的CS-miRNA纳米复合物。复合物的Z平均粒径<200 nm。表面电荷随壳聚糖用量的增加而增加。我们观察到壳聚糖以浓度依赖的方式诱导miRNA的碱基堆积。表面等离子体共振光谱表明,低乙酰化程度的壳聚糖形成的复合物高度稳定,与分子量无关。我们没有发现这些复合物对MCF-7细胞具有细胞毒性的证据。此外,乙酰化程度为12%和29%的CS-miRNA纳米复合物具有生物活性,显示出在MCF-7细胞中成功下调靶mRNA表达。因此,我们的数据表明,CS-miRNA复合物为乳腺癌基因治疗提供了一个有前景的非病毒平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/60606fc67108/srep13567-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/2ee9ed3c23bc/srep13567-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/3bcd36d643eb/srep13567-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/70b2beb7dac5/srep13567-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/f9c2e125fe66/srep13567-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/74d574b2427c/srep13567-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/996337390007/srep13567-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/fd256fa434ac/srep13567-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/60606fc67108/srep13567-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/2ee9ed3c23bc/srep13567-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/3bcd36d643eb/srep13567-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/70b2beb7dac5/srep13567-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/f9c2e125fe66/srep13567-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/74d574b2427c/srep13567-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/996337390007/srep13567-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/fd256fa434ac/srep13567-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b74d/4555168/60606fc67108/srep13567-f8.jpg

相似文献

1
Physicochemical and biological characterization of chitosan-microRNA nanocomplexes for gene delivery to MCF-7 breast cancer cells.用于向MCF-7乳腺癌细胞进行基因递送的壳聚糖-微小RNA纳米复合物的物理化学和生物学特性
Sci Rep. 2015 Sep 1;5:13567. doi: 10.1038/srep13567.
2
In Vitro Dose Studies on Chitosan Nanoplexes for microRNA Delivery in Breast Cancer Cells.壳聚糖纳米复合物用于乳腺癌细胞中微小RNA递送的体外剂量研究
Nucleic Acid Ther. 2017 Feb;27(1):45-55. doi: 10.1089/nat.2016.0633. Epub 2016 Oct 20.
3
Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency.三甲基化壳聚糖作为非病毒基因传递载体:细胞毒性与转染效率
J Control Release. 2005 Apr 18;103(3):643-53. doi: 10.1016/j.jconrel.2005.01.001.
4
Novel hyaluronic acid-chitosan nanoparticles as non-viral gene delivery vectors targeting osteoarthritis.新型透明质酸-壳聚糖纳米粒作为靶向骨关节炎的非病毒基因传递载体。
Int J Pharm. 2011 Nov 28;420(2):358-65. doi: 10.1016/j.ijpharm.2011.08.046. Epub 2011 Sep 3.
5
High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation.使用具有特定分子量和脱乙酰度组合的壳聚糖/DNA纳米颗粒进行高效基因转移。
Biomaterials. 2006 Sep;27(27):4815-24. doi: 10.1016/j.biomaterials.2006.04.029. Epub 2006 May 24.
6
Chitosan as a non-viral co-transfection system in a cystic fibrosis cell line.壳聚糖作为囊性纤维化细胞系中的一种非病毒共转染系统。
Int J Pharm. 2016 Apr 11;502(1-2):1-9. doi: 10.1016/j.ijpharm.2016.01.083. Epub 2016 Feb 11.
7
Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.可磷酸化短肽偶联的低分子量壳聚糖用于高效 siRNA 递送和靶基因沉默。
Int J Pharm. 2012 Jan 17;422(1-2):445-53. doi: 10.1016/j.ijpharm.2011.10.041. Epub 2011 Oct 28.
8
Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.壳聚糖盐作为非病毒基因载体在CHO-K1细胞中的评估。
Int J Pharm. 2008 Feb 4;348(1-2):161-8. doi: 10.1016/j.ijpharm.2007.07.011. Epub 2007 Jul 17.
9
MicroRNA delivery with osmotic polysorbitol-based transporter suppresses breast cancer cell proliferation.基于渗透型聚山梨醇的转运体递送微小RNA可抑制乳腺癌细胞增殖。
Int J Biol Macromol. 2015 Jan;72:1237-43. doi: 10.1016/j.ijbiomac.2014.10.041. Epub 2014 Oct 27.
10
Aerosol-based fabrication of modified chitosans and their application for gene transfection.基于气溶胶的壳聚糖改性及其在基因转染中的应用。
ACS Appl Mater Interfaces. 2014 Apr 9;6(7):4597-602. doi: 10.1021/am501069u. Epub 2014 Mar 18.

引用本文的文献

1
Transmucosal Delivery of miR-30c-5p by Chitosan Nanoparticles for Oral Squamous Cell Carcinoma.壳聚糖纳米颗粒介导miR-30c-5p经黏膜递送用于口腔鳞状细胞癌
Int J Nanomedicine. 2025 Jul 19;20:9179-9194. doi: 10.2147/IJN.S524558. eCollection 2025.
2
MicroRNA-targeted nanoparticle delivery systems for cancer therapy: current status and future prospects.用于癌症治疗的微小RNA靶向纳米颗粒递送系统:现状与未来展望。
Nanomedicine (Lond). 2025 May;20(10):1181-1194. doi: 10.1080/17435889.2025.2492542. Epub 2025 Apr 15.
3
Folic Acid-Decorated Chitosan-PLGA Nanobiopolymers for Targeted Drug Delivery to Acute Lymphoblastic Leukemia Cells: Studies.

本文引用的文献

1
SYBR Gold Fluorescence Quenching is a Sensitive Probe of Chitosan-microRNA Interactions.SYBR Gold荧光猝灭是壳聚糖与微小RNA相互作用的灵敏探针。
J Fluoresc. 2016 Jan;26(1):37-42. doi: 10.1007/s10895-015-1697-8. Epub 2015 Oct 28.
2
MicroRNA and cancer--a brief overview.微小RNA与癌症——简要概述
Adv Biol Regul. 2015 Jan;57:1-9. doi: 10.1016/j.jbior.2014.09.013. Epub 2014 Sep 28.
3
Structure of chitosan determines its interactions with mucin.壳聚糖的结构决定了它与黏蛋白的相互作用。
用于靶向递送药物至急性淋巴细胞白血病细胞的叶酸修饰壳聚糖-聚乳酸-羟基乙酸共聚物纳米生物聚合物:研究
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241308077. doi: 10.1177/15330338241308077.
4
Synthesis and study of surface-modified and anti-EGFR DNA aptamer -conjugated chitosan nanoparticles as a potential targeted drug delivery system.表面修饰且抗表皮生长因子受体(EGFR)DNA适配体偶联的壳聚糖纳米粒作为潜在靶向给药系统的合成与研究
Heliyon. 2024 Oct 5;10(19):e38904. doi: 10.1016/j.heliyon.2024.e38904. eCollection 2024 Oct 15.
5
Stimuli-sensitive Chitosan-based Nanosystems-immobilized Nucleic Acids for Gene Therapy in Breast Cancer and Hepatocellular Carcinoma.基于刺激响应性壳聚糖的纳米系统固定化核酸用于乳腺癌和肝癌的基因治疗。
Curr Top Med Chem. 2024;24(17):1464-1489. doi: 10.2174/0115680266293173240506054439.
6
Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges.基于纳米医学的乳腺癌药物靶向治疗:药代动力学、临床进展与挑战
ACS Omega. 2023 Dec 13;8(51):48625-48649. doi: 10.1021/acsomega.3c07345. eCollection 2023 Dec 26.
7
The important role of miR-1-3p in cancers.miR-1-3p 在癌症中的重要作用。
J Transl Med. 2023 Oct 31;21(1):769. doi: 10.1186/s12967-023-04649-8.
8
The Role of MicroRNAs in Breast Cancer and the Challenges of Their Clinical Application.微小RNA在乳腺癌中的作用及其临床应用面临的挑战。
Diagnostics (Basel). 2023 Sep 28;13(19):3072. doi: 10.3390/diagnostics13193072.
9
The mirrored cationic peptide as miRNA vehicle for efficient lung cancer therapy.作为用于高效肺癌治疗的微小RNA载体的镜像阳离子肽。
MedComm (2020). 2023 Jul 28;4(4):e273. doi: 10.1002/mco2.273. eCollection 2023 Aug.
10
Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.用于核酸递送的壳聚糖基纳米颗粒:技术层面、应用及未来展望
Pharmaceutics. 2023 Jun 29;15(7):1849. doi: 10.3390/pharmaceutics15071849.
Biomacromolecules. 2014 Oct 13;15(10):3550-8. doi: 10.1021/bm5007954. Epub 2014 Sep 4.
4
Non-viral vectors for gene-based therapy.基于基因治疗的非病毒载体。
Nat Rev Genet. 2014 Aug;15(8):541-55. doi: 10.1038/nrg3763. Epub 2014 Jul 15.
5
Tumor suppressor microRNAs: a novel non-coding alliance against cancer.抑癌 microRNAs:一种新型的非编码抗癌联盟。
FEBS Lett. 2014 Aug 19;588(16):2639-52. doi: 10.1016/j.febslet.2014.03.033. Epub 2014 Mar 26.
6
Liposomal siRNA nanocarriers for cancer therapy.用于癌症治疗的脂质体小干扰RNA纳米载体
Adv Drug Deliv Rev. 2014 Feb;66:110-6. doi: 10.1016/j.addr.2013.12.008. Epub 2013 Dec 30.
7
MicroRNAs and other non-coding RNAs as targets for anticancer drug development.微小 RNA 及其他非编码 RNA 作为抗癌药物研发的靶点。
Nat Rev Drug Discov. 2013 Nov;12(11):847-65. doi: 10.1038/nrd4140.
8
Chitosan-based siRNA delivery systems.基于壳聚糖的 siRNA 递送系统。
J Control Release. 2013 Nov 28;172(1):207-218. doi: 10.1016/j.jconrel.2013.08.005. Epub 2013 Aug 18.
9
PAMAM dendrimer roles in gene delivery methods and stem cell research.PAMAM 树枝状聚合物在基因传递方法和干细胞研究中的作用。
Cell Biol Int. 2013 May;37(5):415-9. doi: 10.1002/cbin.10051. Epub 2013 Mar 18.
10
MicroRNA miR-145 inhibits proliferation, invasiveness, and stem cell phenotype of an in vitro endometriosis model by targeting multiple cytoskeletal elements and pluripotency factors.微小 RNA miR-145 通过靶向多个细胞骨架元件和多能性因子抑制体外子宫内膜异位症模型的增殖、侵袭和干细胞表型。
Fertil Steril. 2013 Apr;99(5):1346-1355.e5. doi: 10.1016/j.fertnstert.2012.11.055. Epub 2013 Jan 8.